Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

LEXAPRO 5 MG TABLET

ESCITALOPRAM
$14.7432per EA
High Outlier

Strength

5 mg/1

Manufacturer

Allergan, Inc.

NDC

00456200501

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/2/2026

Active Ingredients

ESCITALOPRAM OXALATE

Approval Type

New Drug (NDA)

FDA Application

NDA021323

On Market Since

8/14/2002

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.1%

1Y

+4.5%

3Y

+13.3%

5Y

+24.9%

All

+204.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

RALDESY 10 MG/ML SOLUTION
Brand
30698045502•Validus Pharmaceuticals LLC
$2.4628
per ML
ZOLOFT 20 MG/ML ORAL CONC
Brand
00049005001•Roerig
$4.5486
per ML
ZOLOFT 20 MG/ML ORAL CONC
Brand
58151060135•Viatris Specialty LLC
$4.5486
per ML
DRIZALMA SPRINKLE DR 60 MG CAP
Brand
47335061930•Sun Pharmaceutical Industries Inc.
$7.1571
per EA
DRIZALMA SPRINKLE DR 40 MG CAP
Brand
47335061830•Sun Pharmaceutical Industries Inc.
$7.1607
per EA
DRIZALMA SPRINKLE DR 20 MG CAP
Brand
47335061630•Sun Pharmaceutical Industries Inc.
$7.1719
per EA
DRIZALMA SPRINKLE DR 30 MG CAP
Brand
47335061730•Sun Pharmaceutical Industries Inc.
$7.2186
per EA
CYMBALTA 20 MG CAPSULE
Brand
00002323560•Eli Lilly and Company
$7.9836
per EA
SAVELLA 50 MG TABLET
Brand
00456155060•Allergan, Inc.
$8.1588
per EA
SAVELLA 12.5 MG TABLET
Brand
00456151260•Allergan, Inc.
$8.1597
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy